Abstract (J Korean Assoc Oral Maxillofac Surg 2012;38:212-20) Objectives: Fluorine-18 fluorodeoxyglucose positron emission tomography ( 18 F-FDG PET) is a non-invasive diagnostic tool for many human cancers wherein glucose uptake transporter-1 (GLUT-1) acts as a main transporter in the uptake of 18 F-FDG in cancer cells. Increased expression of glucose transporter-1 has been reported in many human cancers. In this study, we investigated the correlation between 18 F-FDG accumulation and expression of GLUT-1 in oral cancer. Materials and Methods: We evaluated 42 patients diagnosed with oral squamous cell carcinoma (OSCC) and malignant salivary gland tumor as confirmed by histology. 42 patients underwent pre-operative 18 F-FDG PET, with the maximum standardized uptake value (SUV max ) measured in each case. Immunohistochemical staining was done for each histological specimen, and results were evaluated post-operatively according to the percentage (%) of positive area, intensity, and staining score. Results: For OSCC, SUV max significantly increased as T stage of tumor classification increased. For malignant salivary gland tumor, SUV max significantly increased as T stage of tumor classification increased. For OSCC, GLUT-1 was expressed in all 36 cases. GLUT-1 staining score (GSS) increased as T stage of tumor classification increased, with the difference statistically significant. For malignant salivary gland tumor, GLUT-1 expression was observed in all 6 cases; average GSS was significantly higher in patients with cervical lymph node metastasis than that in patients without cervical lymph node metastasis. Average GSS was higher in OSCC (11.11±1.75) than in malignant salivary gland tumor (5.33±3.50). No statistically significant correlation between GSS and SUV max was observed in OSCC or in malignant salivary gland tumor. Conclusion: We found no statistically significant correlation between GSS and SUV max in OSCC or in malignant salivary gland tumor. Studies on the various uses of GLUT during 18 F-FDG uptake and SUV and GLUT as tumor prognosis factor need to be conducted through further investigation with large samples.
1, GLUT-2, GLUT-3, GLUT-4, GLUT-5, and GLUT-7. The type and degree of their expressions vary according to the different regions and tissues of the body 5 . Currently, the overall expression of GLUT-1 is known to be increasing in various cancer cells such as esophageal cancer, colon cancer, pancreas cancer, non-small cell lung cancer, and brain tumor; this is related to the clinical stage, invasiveness of tumor, remote metastasis, and unfavorable prognosis [6] [7] [8] [9] . This study sought to measure the degree of expression of GLUT-1 in and glycogen as its stored form are the energy source for the aerobic metabolism of the cell. A malignant tumor cell expresses high glucose uptake rate and demand compared with normal cells due to the increase of glucose uptake transporter (GLUT) and enhancement of glycolytic activity 3 . Widely used as the marker substance for PET, 18 F-FDG is an analogue of the glucose flown into the cell competitively with the glucose 4 ; here, glucose and 18 F-FDG are flown into the cell through GLUT, which has 6 subtypes: GLUT- 9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41 42 70  73  71  53  69  78  61  73  75  67  69  67  53  67  61  76  73  76  57  46  64  68  77  57  75  86  32  63  67  71  29  58  29  81  59  33  43  90  78  65  45 SCC MD  SCC WD  SCC WD  SCC MD  SCC MD  SCC WD  SCC WD  SCC WD  SCC WD  SCC WD  SCC WD  SCC MD  SCC MD  SCC WD  SCC MD  SCC WD  SCC WD  SCC WD  SCC WD  SCC WD  SCC WD  MEDC  METC  ACC  ADC  CCC  ACCC   3  2  1  2  2  1  3  2  1  1  2  2  2  2  3  4a  1  1  1  4a  2  1  2  2  3  4a  2  1  2  4  1  1  1  2  2  2  2  3  2  3  2  2   0  0  0  0  2b  1  1  2c  0  0  0  1  1  1  2c  x  0  0  0  2a  0  0  0  0  1  0  0  0  0  1  0  0  0  1  1  0  0  0  0  2c  1 3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  2  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  2  2  2  2  3 
II. Materials and Methods

Object of the study
A retrospective study was conducted on 42 patients who were diagnosed with oral squamous cell carcinoma and malignant salivary gland tumor and who underwent operations from May 2006 to July 2011. All operations were performed by 1 oral and maxillofacial surgeon, and GLUT-1 in the removed tumor tissues was immunohistochemically stained. The study targeted patients who received PETcomputed tomography (CT) before the surgery to check the degree of 18 F-FDG uptake by the tumor inside the oral cavity. No patients received anticancer chemotherapy or anticancer radiation treatments before the surgery, and patients with insulin-dependent diabetes were excluded. At least 24 out of 42 patients were male and 18 were female, with average age of 63.
Tissue samples of 42 patients were collected from the following regions: 12 from gingiva, 12 from palate, 9 from tongue, 5 from oral floor, and 4 from cheek.
Among 42 patients, 29 had well-differentiated type of oral Well-differentiated squamous cell carcinoma confirmed on H&E staining (×400). C. Immunohistochemical staining score for glucose uptake transporter-1 in tumor cells was 12 (strong intensity and more than 75% of positive area) (×400).
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(Epitomic, Burlingame, CA, USA) was diluted at the ratio of 1 : 1,000 and used as the primary antibody.
For the interpretation of the immunohistochemical staining of GLUT-1 antibody, the case wherein it was stained along the cell membrane of the tumor cell was considered positive. Staining was divided into 4 grades according to intensity (0=negative, 1=low, 2=medium, 3=high) and analyzed was reexamined, and typical paraffin blocks for the tumor of each patient were selected. The paraffin block was sliced into 4 μ m thick pieces and deparaffined and hydrated. All immunohistochemical staining processes were automated with the Bond Polymer Refine Detection (Leica Biosystems, Newcastle, UK) system. The antigen retrieval process was skipped, and anti-GLUT-1 rabbit monoclonal antibody (Table 3) 2. Correlation between SUV max and T, N stage in mali gnant salivary gland tumor
The average SUV max of a total of 6 samples was 6.18±2.58. SUV max tended to have higher statistical significance with higher T stage (P=0.004) but no correlation with cervical lymphatic metastasis (P=0.726). (Table 4) separately in 4 grades (1=0-25%, 2=25-50%, 3=50-75%, 4=75-100%) according to the percentage of positively stained tumor cell. The result of multiplication of two variables (GLUT-1 staining score) was used as GLUT-1 staining score (GSS). Pathological slides were read by one pathologist without providing the clinical information of patients. (Table 2) 3. Statistical method
The T, N stage and SUV max of tumor and GLUT-1 expression score in tumor cell were expressed in the form of average±standard deviation. SPSS version 12.0 (SPSS Inc., Chicago, IL, USA) was used as the statistical program for the comparative analysis of the measurements; ANOVA was used for the comparison of average between groups, and Pearson's correlation test, for the correlation between SUV max and GSS. Results were considered statistically significant when P-value was less than 0.05. F-FDG is distributed evenly throughout the body when it is administered, enabling comparison between patients. Normal tissue has the same 18 F-FDG distribution, i.e., SUV is close to 1, but abnormal tissues such as cancer increase uptake unlike their proximate tissues; thus enabling the calculation of relative uptake increase rate compared with normal tissues 4 . This is used for the discrimination of malignant tumor and benign tumor, carrying great significance in evaluating the response after tumor treatment and determining the prognosis of tumor [10] [11] [12] . Thus, despite the high cost, the application scope of PET is gradually broadening.
A variety of studies were conducted on the correlation between the prognosis of head and neck cancer patients and SUV. Minn et al. 13 reported that the prognosis was more unfavorable when SUV was high in the case of 37 head
Correlation between GSS and histological diffe renti ation, T, N stage in oral squamous cell carci noma
GLUT-1 expression was observed in all 36 samples, and average GSS was measured to be 11.11±1.75. GSS according to histological differentiation did not have statistical significance (P=0.176), tending to have higher statistical significance with higher T stage (P=0.017) but no correlation with cervical lymphatic metastasis (P=0.509). (Table 5) 4. Correlation between GSS and T, N stage in malignant salivary gland tumor GLUT-1 expression was observed in all 6 samples, and average GSS was measured to be 5.33±3.50. GSS according to T stage did not have statistical significance (P =0.89). Note, however, that GSS in patients with cervical lymphatic metastasis showed higher statistical significance compared with that in patients without cervical lymphatic metastasis (P=0.049). (Table 6) 5. Correlation between SUV max and GSS in oral squamous cell carcinoma
There was positive correlation between GSS and SUV max , but such was not statistically significant (r=0.058, P=0.738). (Table 7) 6. Correlation between SUV max and GSS in malignant salivary gland tumor
There was no significant correlation between GSS and SUV max (r=-0.099, P=0.852). (Table 8 ) increase of hexokinase activity, proliferation speed of cancer cells, distribution of macrophagocytes, and size of cancer 22, 23 . Among these elements, the high expression of GLUT-1 was reportedly unfavorable to the prognosis of tumor, lowering the survival rate 15 . GLUT was found to express tissue specifically, with GLUT-1 mostly detected in red blood cell and vascular tissue and GLUT-3 mainly expressed in cerebral tissues and inflammatory cells 24 . In particular, the overexpression of GLUT in head and neck squamous cell carcinoma was reported to be common, and GLUT-1 and 3 were frequently expressed in patients with lymphatic metastasis 25, 26 . In this study, GLUT-1 in oral squamous cell carcinoma did not have statistical significance in relation to cervical lymphatic metastasis. Note, however, that GLUT-1 was expressed actively in patients with malignant salivary gland tumor and lymphatic metastasis, with the correlation statistically significant.
According to recent studies, the expression of squamous cell carcinoma, which occurs in the head and neck region, shows close relationship with the T stage of the tumor and histological differentiation [18] [19] [20] [21] . Tian et al. 27 reported that the degree of GLUT-1 expression had low correlation with SUV since SUV was high, but the expression of GLUT-1 was low when the ratio of inflammatory cell increased relatively, and that both SUV and GLUT-1 were high when the ratio of tumor cell increased relatively since the ratio of tumor cells and inflammatory cells in cancer varied according to the region of body and GLUT-1 was expressed more in the tumor cell than the inflammatory tissue. Similarly, positive correlation was noted between GSS and SUV in oral squamous cell carcinoma in this study. Thus, the type and degree of GLUT-1 were deduced to form part of the factors influencing SUV max , but they did not have statistically significant correlation. This could be explained by the fact that GLUT-1 was expressed intensively in all oral squamous cell carcinomas, but the difference between the degrees of expression was not statistically significant; in fact, it was difficult to find changes in SUV max in PET scan. Furthermore, it would be difficult to ignore the influence of the local volume effect occurring during the measurement of SUV and error due to the uptake period of the radiotracer. There were differences in the degree of expression of GLUT-1 according to the ratio of inflammatory cell within the tumor; the subtype of GLUT may exist in great diversity according to each tumor, including the effect of different paths related to glucose uptake such as the hexokinase enzyme system on different tumors. The correlation between SUV and GLUTand neck squamous cell carcinoma patients. According to Torizuka et al. 14 , more aggressive treatment must be considered when FDG uptake is higher, based on their examination of 50 head and neck squamous cell carcinoma patients. Kunkel et al. 15 stated that the group with belowaverage SUV showed significant increase of survival rate compared with the group with above-average SUV.
A few possibilities are suggested as to the reason for having more unfavorable prognosis when SUV is higher in PET. First, the size of cancer is large in patients wherein the tumor has progressed; thus, the number of cells in the tumor is reflected on SUV. In fact, the study on lung cancer showed that SUV as well as the size of cancer can be used as prognosis-estimating factor 16 . Second, patients whose cancer is progressing exhibit deterioration of overall health and abnormal glucose metabolism, with 18 F-FDG uptake increasing in proportion to the speed of cell division and proliferation of cancer 13 . Third, there are studies reporting low histological differentiation given high SUV, weakening the effect of anticancer chemotherapy or radiation treatment. As such, PET was cited as a factor in estimating prognosis independently for head and neck cancer 17 . According to recent studies, SUV showed significant correlation with the T stage of the tumor and histological differentiation in squamous cell carcinoma in the head and neck [18] [19] [20] [21] . In this study, T stage was higher when SUV max was high in oral squamous cell carcinoma, showing statistically significant result but no significant correlation between SUV max and histological differentiation of tumor. The malignant salivary gland tumor also showed statistically significant result since T stage was high when SUV max was high.
PET has limits in showing the anatomical structure compared with CT or magnetic resonance imaging. More over, since it reflects the tissue with high glucose meta bolism, the uptake of marker substance can increase in organs with active glucose metabolism such as brain, tonsil tissue, and salivary gland as well as inflammatory tissues and in organs excreting the marker substance such as kidney and bladder; thus displaying less discrimination capacity for organs 4, 7 . For this, studies are being conducted from various viewpoints to find the elements that increase 18 F-FDG uptake by malignant tumor and influence diagnostic sensitivity in the discrimination and diagnosis with benign tissues. Studies are currently conducted as well with regard to the correlation between 18 F-FDG uptake and expression of GLUT-1 in relation to the increase of glucose metabolism of cancer cell, 1 seemed to be weakened by these effects. Note, however, that there was correlation between the expression of GLUT-1 and 18 F-FDG uptake in non-small cancer cells in the lung, colon cancer, and sarcoma 9, 18, 28 . A few previous studies also reported clinical correlation between glucose metabolism and PET image 13, 15, 29 . An in-depth study of the role of GLUT-1 related to 18 F-FDG uptake and the correlation with SUV is expected to yield meaningful outcomes.
V. Conclusion
This study investigated the correlation between T, N stage, histological differentiation of tumor, and total expression score related to the rate and intensity of GLUT-1 expression and SUV max among 42 patients who were diagnosed with oral squamous cell carcinoma and malignant salivary gland tumor and who had surgery after receiving PET-CT scan at the Department of Oral and Maxillofacial Surgery, School of Dentistry, Dankook University from May 2006 to July 2011. As a result, the following conclusions were drawn:
1. Higher SUV max was obtained with higher T stage in oral squamous cell carcinoma, indicating high statistical significance (P=0.007). 2. Higher SUV max was obtained with higher T stage in malignant salivary gland tumor, indicating high statistical significance (P=0.004). 3. Glut-1 expression was observed in all 36 samples of oral squamous cell carcinoma, and higher GSS was obtained with higher T. The difference was statistically significant (P=0.017). 4. Glut-1 expression was observed in all 6 samples of malignant salivary gland tumor, with the average GSS among patients with cervical lymphatic metastasis showing higher statistical significance compared with that among patients without cervical lymphatic metastasis (P=0.049). 5. The average GSS (11.11±1.75) of oral squamous cell carcinoma was higher than the average GSS (5.33±3.50) of malignant salivary gland tumor. 6. No significant correlation was found between GSS and SUV max in oral squamous cell carcinoma (r=0.058, P=0.738) or in malignant salivary gland tumor (r=-0.099, P=0.852). According to the findings above, studies on the use of various types of GLUT related to 18 F-FDG uptake and on SUV and GLUT as prognostic factors of the tumor with a large number of samples are additionally needed in the future.
